Insider · CIK 0001304406
Stephen C. Glover
Files at PDSB (PDS Biotechnology Corp), ZVSA (ZyVersa Therapeutics, Inc.). First filing Mar 3, 2025, latest Mar 3, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PDSB: PDS Biotechnology Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | PDS Biotechnology Corp | $25k 15,061 shares | +24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | ZVSA ZyVersa Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +136,900 | $0.00 | $0 | 136,900 | Jul 15, 2025 |
| Jun 11, 2025 | PDSB PDS Biotechnology Corp | AGrant or award Employee Stock Option (Right to Buy)derivative | +22,700 | $0.00 | $0 | 22,700 | Jun 11, 2025 |
| Feb 28, 2025 | PDSB PDS Biotechnology Corp | POpen-market purchase Common Stock | +15,061 | $1.66 | $25k | 78,851 | Mar 3, 2025 |
| Feb 28, 2025 | PDSB PDS Biotechnology Corp | POpen-market purchase Common Warrantderivative | +15,061 | - | - | 15,061 | Mar 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.